{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:33:21Z","timestamp":1780346001785,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canrad.2025.104668","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:12:15Z","timestamp":1751955135000},"page":"104668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Observation of the efficacy and safety of concurrent intensity-modulated radiation with 5-fluorouracil and oxaliplatin for locally advanced nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Li","family":"Yanbing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Lingyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Hongbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zijun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canrad.2025.104668_bib0075","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00405-020-06399-5","article-title":"Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy","volume":"278","author":"Lyu","year":"2021","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.canrad.2025.104668_bib0080","doi-asserted-by":"crossref","first-page":"1010131","DOI":"10.3389\/fonc.2022.1010131","article-title":"Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma","volume":"12","author":"Fang","year":"2022","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.canrad.2025.104668_bib0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamaoto.2022.2791","article-title":"Cetuximab-based vs carboplatin-based chemoradiotherapy for patients with head and neck cancer","volume":"148","author":"Sun","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.canrad.2025.104668_bib0090","doi-asserted-by":"crossref","first-page":"907","DOI":"10.6004\/jnccn.2020.7594","article-title":"Combining systemic therapy with radiation: head and neck cancer treatments in an era of targeted agents and immunotherapy","volume":"18","author":"Vasudevan","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.canrad.2025.104668_bib0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12885-021-07823-7","article-title":"Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis","volume":"21","author":"Kawai","year":"2021","journal-title":"BMC Cancer"},{"issue":"5.5","key":"10.1016\/j.canrad.2025.104668_bib0100","first-page":"529","article-title":"The NCCN 2019 annual conference: Improving the quality, effectiveness, and efficiency of cancer care","volume":"17","author":"Carlson","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canrad.2025.104668_bib0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2407-12-98","article-title":"Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence","volume":"12","author":"Ho","year":"2012","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.canrad.2025.104668_bib0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104668_bib0115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaoncol.2020.1808","article-title":"Efficacy and safety of locoregional radiotherapy with chemotherapy vs. chemotherapy alone in de novo metastatic nasopharyngeal carcinoma: a multicenter phase 3 randomized clinical trial","volume":"6","author":"You","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104668_bib0120","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12967-023-04673-8","article-title":"Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect","volume":"21","author":"Siak","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.canrad.2025.104668_bib0145","series-title":"Metallo-drugs: development and action of anticancer agents","first-page":"1","article-title":"Cisplatin and oxaliplatin: our current understanding of their actions","author":"Riddell","year":"2018"},{"key":"10.1016\/j.canrad.2025.104668_bib0130","doi-asserted-by":"crossref","first-page":"1259331","DOI":"10.3389\/fonc.2023.1259331","article-title":"Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.canrad.2025.104668_bib0135","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.canrad.2025.104668_bib0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.6004\/jnccn.2018.7110","article-title":"Efficacy of oral cryotherapy during oxaliplatin infusion in preventing oral thermal hyperalgesia: a randomized trial","volume":"17","author":"Bauman","year":"2019","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:39:54Z","timestamp":1762367994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1278321825000848"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104668","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observation of the efficacy and safety of concurrent intensity-modulated radiation with 5-fluorouracil and oxaliplatin for locally advanced nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104668"}}